Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 19 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Germanidis, Georgios  [Clear All Filters]
Journal Article
Arvanitakis, K., Siargkas A., Germanidis G., Dagklis T., & Tsakiridis I. (2023).  Adverse pregnancy outcomes in women with celiac disease: a systematic review and meta-analysis.. Ann Gastroenterol. 36(1), 12-24.
Germanidis, G., Hytiroglou P., Vassiliadis T., & Speletas M. (2018).  Checkpoint modulation in chronic hepatitis B: From hypothesis to approval.. Hepatology. 67(3), 1175-1176.
Gbandi, E., Goulas A., Sevastianos V., Hadziyannis S., Panderi A., Koskinas J., et al. (2016).  Common ABCB1 polymorphisms in Greek patients with chronic hepatitis C infection: A comparison with hyperlipidemic patients and the general population.. Pharmacol Rep. 68(2), 476-82.
Lazaridis, N., & Germanidis G. (2018).  Current insights into the innate immune system dysfunction in irritable bowel syndrome.. Ann Gastroenterol. 31(2), 171-187.
Speletas, M., Argentou N., Germanidis G., Vasiliadis T., Mantzoukis K., Patsiaoura K., et al. (2011).  Foxp3 expression in liver correlates with the degree but not the cause of inflammation.. Mediators Inflamm. 2011, 827565.
Ribeiro, R. M., Germanidis G., Powers K. A., Pellegrin B., Nikolaidis P., Perelson A. S., et al. (2010).  Hepatitis B virus kinetics under antiviral therapy sheds light on differences in hepatitis B e antigen positive and negative infections.. J Infect Dis. 202(9), 1309-18.
Sarafidis, P. A., Georgianos P. I., Germanidis G., Giavroglou C., Nikolaidis P., Lasaridis A. N., et al. (2012).  Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferative glomerulonephritis.. Am J Kidney Dis. 59(3), 434-8.
Germanidis, G., Argentou N., Hytiroglou P., Vassiliadis T., Patsiaoura K., Germenis A. E., et al. (2013).  Liver FOXP3 and PD1/PDL1 Expression is Down-Regulated in Chronic HBV Hepatitis on Maintained Remission Related to the Degree of Inflammation.. Front Immunol. 4, 207.
Chrysanthidis, T., Loli G., Metallidis S., & Germanidis G. (2017).  Mechanisms of accelerated liver fibrosis in HIV-HCV coinfection.. AIDS Rev. 19(3), 148-155.
Metallidis, S., Tsachouridou O., Skoura L., Zebekakis P., Chrysanthidis T., Pilalas D., et al. (2013).  Older HIV-infected patients--an underestimated population in northern Greece: epidemiology, risk of disease progression and death.. Int J Infect Dis. 17(10), e883-91.
Tsachouridou, O., Christaki E., Skoura L., Georgiou A., Nanoudis S., Vasdeki D., et al. (2017).  Predictors of humoral response to recommended vaccines in HIV-infected adults.. Comp Immunol Microbiol Infect Dis. 54, 27-33.
Germanidis, G., Hytiroglou P., Zakalka M., & Settas L. (2012).  Reactivation of occult hepatitis B virus infection, following treatment of refractory rheumatoid arthritis with abatacept.. J Hepatol. 56(6), 1420-1.
Raoul, J-L., Bruix J., Greten T. F., Sherman M., Mazzaferro V., Hilgard P., et al. (2012).  Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses.. J Hepatol. 56(5), 1080-8.
Molyvdas, A., Georgopoulou U., Lazaridis N., Hytiroglou P., Dimitriadis A., Foka P., et al. (2018).  The role of the NLRP3 inflammasome and the activation of IL-1β in the pathogenesis of chronic viral hepatic inflammation.. Cytokine. 110, 389-396.
Morice, Y., Ratinier M., Miladi A., Chevaliez S., Germanidis G., Wedemeyer H., et al. (2009).  Seroconversion to hepatitis C virus alternate reading frame protein during acute infection.. Hepatology. 49(5), 1449-59.
Argentou, N., Germanidis G., Hytiroglou P., Apostolou E., Vassiliadis T., Patsiaoura K., et al. (2016).  TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment.. Inflamm Res. 65(5), 355-65.
Hayer, J., Rodriguez C., Germanidis G., Deléage G., Zoulim F., Pawlotsky J-M., et al. (2014).  Ultradeep pyrosequencing and molecular modeling identify key structural features of hepatitis B virus RNase H, a putative target for antiviral intervention.. J Virol. 88(1), 574-82.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.. Metabolism. 71, 17-32.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism. 71, 17 - 32.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.